Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

Clinical trial NCT04768062 · UNKNOWN

Trial details

NCT number: NCT04768062
Sponsor: NS Pharma, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2021-04-13
Primary completion: 2025-10-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.